Granules India announced that Granules Consumer Health (GCH), a step-down subsidiary of the Company and a wholly owned subsidiary of Granules USA, Inc., has completed an audit by the US Food and Drug Administration (US FDA) with zero 483s.

The facility was inspected by the US FDA from March 15 to 20, 2023. "The audit is a pre-approval inspection for three products filed from the facility. The packaging site strengthens our proposition to control the value chain and provides us with the agility needed in a very dynamic OTC space," said Priyanka Chigurupati, Executive- Director, Granules USA & Granules Pharmaceuticals.

Granules Consumer Health (GCH) is a leading private-label OTC provider, and its packaging facility will enable it to service leading retailers more effectively.

The packaging facility in Manassas is spread over 79,000 sq ft and has several packaging suites to service customer needs.